Hygrovest Limited (HGV.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -189 Thousand AUD | 94.91% |
| 2023 | -3.71 Million AUD | 41.21% |
| 2022 | -6.31 Million AUD | -83.43% |
| 2021 | -3.44 Million AUD | -230.61% |
| 2020 | -1.04 Million AUD | 96.05% |
| 2019 | -26.39 Million AUD | -1859.32% |
| 2018 | -1.34 Million AUD | 94.36% |
| 2017 | -23.86 Million AUD | -869.69% |
| 2016 | -2.46 Million AUD | -28.85% |
| 2015 | -1.91 Million AUD | 61.07% |
| 2014 | -4.9 Million AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -328 Thousand AUD | 91.17% |
| 2024 Q2 | -328 Thousand AUD | 0.0% |
| 2024 Q4 | -189 Thousand AUD | 0.0% |
| 2024 FY | -189 Thousand AUD | 94.91% |
| 2023 Q2 | -4.7 Million AUD | 0.0% |
| 2023 Q4 | -3.71 Million AUD | 0.0% |
| 2023 FY | -3.71 Million AUD | 41.21% |
| 2023 Q3 | -3.71 Million AUD | 21.06% |
| 2023 Q1 | -4.7 Million AUD | 25.53% |
| 2022 Q4 | -6.31 Million AUD | 0.0% |
| 2022 Q2 | -4.05 Million AUD | 0.0% |
| 2022 FY | -6.31 Million AUD | -83.43% |
| 2022 Q1 | -4.05 Million AUD | -17.82% |
| 2022 Q3 | -6.31 Million AUD | -55.68% |
| 2021 Q1 | -3.81 Million AUD | -266.31% |
| 2021 FY | -3.44 Million AUD | -230.61% |
| 2021 Q4 | -3.44 Million AUD | 0.0% |
| 2021 Q3 | -3.44 Million AUD | 9.75% |
| 2021 Q2 | -3.81 Million AUD | 0.0% |
| 2020 FY | -1.04 Million AUD | 96.05% |
| 2020 Q1 | -8.27 Million AUD | 68.63% |
| 2020 Q2 | -8.27 Million AUD | 0.0% |
| 2020 Q4 | -1.04 Million AUD | 0.0% |
| 2020 Q3 | -1.04 Million AUD | 87.41% |
| 2019 FY | -26.39 Million AUD | -1859.32% |
| 2019 Q2 | -2.61 Million AUD | 0.0% |
| 2019 Q3 | -26.39 Million AUD | -907.71% |
| 2019 Q1 | -2.61 Million AUD | -94.43% |
| 2019 Q4 | -26.39 Million AUD | 0.0% |
| 2018 Q1 | -29.01 Million AUD | -21.92% |
| 2018 Q4 | -1.34 Million AUD | 0.0% |
| 2018 Q3 | -1.34 Million AUD | 95.36% |
| 2018 Q2 | -29.01 Million AUD | 0.0% |
| 2018 FY | -1.34 Million AUD | 94.36% |
| 2017 Q2 | -2.75 Million AUD | 0.0% |
| 2017 FY | -23.86 Million AUD | -869.69% |
| 2017 Q4 | -23.8 Million AUD | 0.0% |
| 2017 Q3 | -23.8 Million AUD | -763.61% |
| 2017 Q1 | -2.75 Million AUD | -11.99% |
| 2016 FY | -2.46 Million AUD | -28.85% |
| 2016 Q1 | -1.36 Million AUD | 0.0% |
| 2016 Q4 | -2.46 Million AUD | 0.0% |
| 2016 Q3 | -2.46 Million AUD | -79.77% |
| 2016 Q2 | -1.36 Million AUD | 0.0% |
| 2015 FY | -1.91 Million AUD | 61.07% |
| 2015 Q2 | 359.14 Thousand AUD | 200.0% |
| 2015 Q1 | -359.14 Thousand AUD | 0.0% |
| 2014 FY | -4.9 Million AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Althea Group Holdings Limited | 641 Thousand AUD | 129.485% |
| Cann Group Limited | 70.82 Million AUD | 100.267% |
| ECS Botanics Holdings Ltd | -2.13 Million AUD | 91.142% |
| Ecofibre Limited | 18.75 Million AUD | 101.008% |
| Elixinol Wellness Limited | 554 Thousand AUD | 134.116% |
| IDT Australia Limited | 3.96 Million AUD | 104.768% |
| Invion Limited | -783.52 Thousand AUD | 75.878% |
| Little Green Pharma Ltd | -532.33 Thousand AUD | 64.496% |
| Live Verdure Ltd | -1.08 Million AUD | 82.512% |
| Medical Developments International Limited | -7.44 Million AUD | 97.463% |
| Vitura Health Limited | -6.02 Million AUD | 96.865% |
| Vita Life Sciences Limited | -24.24 Million AUD | 99.22% |